MARSHALL B. BLOCK, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: I am writing in response to an article by Rendell and associates in the February issue (1). It contains the following statement: "It is interesting that normal fasting and postprandial C-peptide levels were found before tolbutamide administration." The authors then speculate that since C-peptide levels reflect endogenous insulin secretion in normal subjects, in their patient normal endogenous insulin secretion was occurring but that perhaps "an extra pancreatic factor" may have hindered the action of the endogenous insulin.
Unless fractionated C-peptide determinations were done in Dr. Rubenstein's laboratory, it would be extremely difficult to ascertain whether most of
BLOCK MB. C-Peptide Assay. Ann Intern Med. 1979;91:131. doi: https://doi.org/10.7326/0003-4819-91-1-131_1
Download citation file:
Published: Ann Intern Med. 1979;91(1):131.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use